Local IL-17 gene therapy accelerates collagen arthritis with severe bone erosion and rank ligand and rank expression in synovial infiltrate and at bone erosion sites

Similar Items

• Neutralizing synovial RANKL by local OPG gene therapy in collagen-induced arthritis prevents cartilage erosion through induction of a non-destructive type 2 synovitis
  od: Lubberts, E, i dr.
  Izdano: (2004)
• Requirement of local synovial IL-17 receptor signaling in the progression of chronic synovitis and bone erosion in arthritis
  od: Lubberts, E, i dr.
  Izdano: (2004)
• IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion
  od: Lubberts, Erik, i dr.
  Izdano: (2000)
• Neutralizing IL-17 during re-activation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and IL-1
  od: Koenders, MI, i dr.
  Izdano: (2005)
• IL-1-dependent cartilage damage in a macrophage-driven arthritis model can be circumvented by T cell IL-17
  od: Koenders, MI, i dr.
  Izdano: (2004)